2 completed, 1 recruiting. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow ASD: new trials by email Literature Review of ASD trials Research Report on ASD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Spironolactone Improved Children With Gene Mutations Related to NCOR .spironolactone - NCOR Gene Mutations, Spironolactone | Phase 2 / Phase 3 | Recruiting | Qilu Hospital of Shandong University | 2 | 2024-10-30 | 2026-05-18 |
| Intranasal Vasopressin Treatment in Children With Autism Vasopressin (USP) Injectable Solution [Vasostrict], Placebo - Autism, Autism Spectrum Disorder | Phase 2 / Phase 3 | Completed | Stanford University | 157 | 2018-02-20 | 2026-06-04 |
| A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder Intranasal Oxytocin - Autism Spectrum Disorder, Pervasive Developmental Disorder | Phase 3 | Completed | Massachusetts General Hospital | 7 | 2017-10-09 | 2024-07-01 |
Autism Spectrum Disorder (2) · Autistic Disorder (1) · Child Development Disorders, Pervasive (1)
Mental Disorders (2) · Neurodevelopmental Disorders (2) · Child Development Disorders, Pervasive (1)
Arginine Vasopressin (1) · Oxytocin (1) · Spironolactone (1) · Vasopressins (1)
Massachusetts General Hospital (1) · Qilu Hospital of Shandong University (1) · Stanford University (1)
United States (2) · China (1)
Antonio Y. Hardan, M.D. (1) · Gagan Joshi, MD (1) · Karen J. Parker, Ph.D. (1)
R01HD091972 (1)